Omnisystem Reports Net Profit Turnaround in Q1 2026, Continues Share Buyback and Cancellation
Consolidated revenue: 18.36bn KRW (down from 27.23bn KRW in prior-year quarter); operating loss 0.29bn KRW (continued loss); net profit 0.97bn KRW (turnaround from net loss of 0.53bn KRW). Non-operating income (forex & valuation gains) drove the profit.
Standalone revenue: 15.48bn KRW; operating loss 0.16bn KRW; net profit 1.28bn KRW (up from 0.41bn KRW).
Additional cancellation of 55,087 treasury shares (Mar 26, 2026). Total 2,055,087 shares cancelled since Apr 2025. No treasury shares remaining.
New short-term loan of 5.4bn KRW to related party Ostin Pharma (total 8.4bn KRW). Sales to Biosmart: 6.03bn KRW.
Continued investment in new businesses: EV chargers, ESS, SWM. Cumulative EV charger sales approx. 10bn KRW from 2024 to Q1 2026.
Consolidated debt ratio 18.5%; cash equivalents 13.37bn KRW vs short-term borrowings 5.14bn KRW. Sound financial structure.
All three subsidiaries (Wizit Energy, Dongdo LMS, OMNISYSTEM VN JSC) reported operating losses or net losses.